...
首页> 外文期刊>Gynecologic Oncology: An International Journal >B7-H4 (DD-O110) is overexpressed in high risk uterine endometrioid adenocarcinomas and inversely correlated with tumor T-cell infiltration.
【24h】

B7-H4 (DD-O110) is overexpressed in high risk uterine endometrioid adenocarcinomas and inversely correlated with tumor T-cell infiltration.

机译:B7-H4(DD-O110)在高危子宫内膜样腺癌中过表达,并且与肿瘤T细胞浸润呈负相关。

获取原文
获取原文并翻译 | 示例

摘要

OBJECTIVES AND METHODS: B7-H4 (DD-O110), a member of the B7 family, negatively regulates T cell-mediated immune response. Previous studies have shown that B7-H4 is highly expressed in endometrioid ovarian cancers with relatively low levels of expression in normal ovary which was confirmed by Western blot. The present study was designed to localize B7-H4 expression by immunohistochemistry (IHC) in normal endometrium, endometrial hyperplasia and uterine endometrioid adenocarcinoma. The pattern of B7-H4 localization was compared with the IHC detection of CD3 and CD8-positive T lymphocytes and CD14 positive macrophages to investigate the role of B7-H4 in the regulation of tumor immune surveillance. B7-H4 expression was evaluated in apoptotic tumor cells. RESULTS: The proportion and intensity of B7-H4 staining were increased in the progression from normal, hyperplastic and malignant endometrial glandular mucosa. B7-H4 showed a predominantly apical membranous staining (pattern 1) in normal and hyperplastic endometrial epithelium but showed intense circumferential membranous and cytoplasmic staining (pattern 2) in a majority of endometrioid carcinoma cases (p=0.018). The proportion of B7-H4 positive tumor cells and staining intensity was also higher in high risk tumors than in low risk tumors (p=0.001 and p=0.032, respectively). The proportion of B7-H4 positive tumor cells was inversely related to the number of CD3-positive and CD8-positive tumor-associated lymphocytes (TALs). There was a positive correlation between B7-H4 pattern 2 staining and both CD3-positive and CD8-positive tumor-infiltrating lymphocytes (TILs) (p=0.039 and p=0.031, respectively). CONCLUSIONS: B7-H4 is overexpressed in hyperplastic and malignant endometrial epithelium and is correlated with the number T cells associated with the tumor. These results suggest that B7-H4 overexpression may reflect a more aggressive biologic potential and may play a role in tumor immune surveillance mechanisms.
机译:目的和方法:B7-H4(DD-O110)是B7家族的成员,对T细胞介导的免疫反应具有负调节作用。先前的研究表明,B7-H4在子宫内膜样卵巢癌中高表达,而在正常卵巢中的表达水平相对较低,这已通过Western印迹证实。本研究旨在通过免疫组织化学(IHC)在正常子宫内膜,子宫内膜增生和子宫内膜样腺癌中定位B7-H4表达。将B7-H4的定位模式与CD3和CD8阳性T淋巴细胞以及CD14阳性巨噬细胞的IHC检测进行了比较,以研究B7-H4在调节肿瘤免疫监视中的作用。在凋亡肿瘤细胞中评估B7-H4表达。结果:随着正常,增生和恶性子宫内膜腺黏膜的进展,B7-H4染色的比例和强度增加。 B7-H4在正常和增生的子宫内膜上皮细胞中主要表现为顶端膜状染色(模式1),但在大多数子宫内膜样癌病例中表现为强烈的外周膜和细胞质染色(模式2)(p = 0.018)。高风险肿瘤中B7-H4阳性肿瘤细胞的比例和染色强度也比低风险肿瘤中更高(分别为p = 0.001和p = 0.032)。 B7-H4阳性肿瘤细胞的比例与CD3阳性和CD8阳性的肿瘤相关淋巴细胞(TAL)的数量成反比。 B7-H4模式2染色与CD3阳性和CD8阳性的肿瘤浸润淋巴细胞(TIL)之间存在正相关(分别为p = 0.039和p = 0.031)。结论:B7-H4在增生性和恶性子宫内膜上皮细胞中过表达,并且与肿瘤相关的T细胞数量有关。这些结果表明,B7-H4的过表达可能反映了更具侵略性的生物学潜力,并可能在肿瘤免疫监视机制中起作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号